Table 5.
Multivariable analyses for COVID-19 related death.
B | S.E. | Sig. | Exp (B) | |
---|---|---|---|---|
Pirfenidone use | −20.50 | 11,783.60 | 0.99 | 0.00 |
Comorbidity | 19.41 | 40,192.96 | 1.00 | 2.69 |
LTOT | −0.92 | 1.823 | 0.61 | 0.39 |
BMI, kg/m2 | 0.28 | 0.25 | 0.27 | 1.32 |
FVC,% | 0.04 | 0.04 | 0.31 | 1.04 |
DLCO,% | −0.11 | 0.07 | 0.14 | 0.89 |
Corticosteroid treatment | 18.61 | 24,029.17 | 0.99 | 1.21 |
LTOT: long term oxygen treatment; BMI: Body mass index.